TY - JOUR
T1 - Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part I
T2 - Classification, diagnosis and staging
AU - Working Group
AU - Alvaro, Domenico
AU - Hassan, Cesare
AU - Cardinale, Vincenzo
AU - Carpino, Guido
AU - Fabris, Luca
AU - Gringeri, Enrico
AU - Granata, Vincenza
AU - Mutignani, Massimiliano
AU - Morement, Helen
AU - Giuliante, Felice
AU - Guglielmi, Alfredo
AU - Ridola, Lorenzo
AU - Marzioni, Marco
AU - Grazi, Gianluca
AU - Guido, Maria
AU - Giulio, Emilio Di
AU - Tonini, Giuseppe
AU - Pantano, Francesco
AU - Venere, Rosanna
AU - Bragazzi, Maria Consiglia
AU - Biancanello, Francesca
AU - Faccioli, Jessica
AU - Giannetti, Aurora
AU - Cintolo, Marcello
AU - Giunta, Michela Di
AU - Gambato, Martina
AU - Lasagni, Alberto
AU - Izzo, Francesco
AU - Avallone, Antonio
AU - Banales, Jesus
AU - Rossi, Massimo
AU - Catalano, Carlo
AU - Laghi, Andrea
AU - D'amati, Giulia
AU - Mancino, Maria Grazia
PY - 2020
Y1 - 2020
N2 - Cholangiocarcinoma (CCA) is the second most common primary liver cancer, characterized by a poor prognosis and resistance to chemotherapeutics. The progressive increase in CCA incidence and mortality registered worldwide in the last two decades and the need to clarify various aspects of clinical management have prompted the Italian Association for the Study of the Liver (AISF) to commission the drafting of dedicated guidelines in collaboration with a group of Italian scientific societies. These guidelines have been formulated in accordance with the Italian National Institute of Health indications and developed by following the GRADE method and related advancements.
AB - Cholangiocarcinoma (CCA) is the second most common primary liver cancer, characterized by a poor prognosis and resistance to chemotherapeutics. The progressive increase in CCA incidence and mortality registered worldwide in the last two decades and the need to clarify various aspects of clinical management have prompted the Italian Association for the Study of the Liver (AISF) to commission the drafting of dedicated guidelines in collaboration with a group of Italian scientific societies. These guidelines have been formulated in accordance with the Italian National Institute of Health indications and developed by following the GRADE method and related advancements.
KW - Distal cholangiocarcinoma
KW - Gene mutations
KW - Histology
KW - Intrahepatic cholangiocarcinoma
KW - Perihilar cholangiocarcinoma
KW - Risk factors
KW - Staging
UR - http://www.scopus.com/inward/record.url?scp=85090489680&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85090489680&partnerID=8YFLogxK
U2 - 10.1016/j.dld.2020.06.045
DO - 10.1016/j.dld.2020.06.045
M3 - Review article
C2 - 32893173
AN - SCOPUS:85090489680
JO - Digestive and Liver Disease
JF - Digestive and Liver Disease
SN - 1590-8658
ER -